| Company Name: |
ChemShuttle, Inc.
|
| Tel: |
0510-83588313-802 18800520310; |
| Email: |
sales@chemshuttle.com |
| Products Intro: |
Product Name:N-(tert-butyl)-6,7-dichloro-3-(methylsulfonyl)quinoxalin-2-amine
CAS:281209-71-0
Purity:95% Package:5mg;25mg;100mg;500mg;1g;5g;10g;25g;50g;100g;250g;500g;kg…
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:GLP-1R agonist DMB
CAS:281209-71-0
Purity:99% Remarks:GLP-1R agonist DMB is a glucagon-like peptide-1 (GLP-1) receptor agonist used potentially for the treatment of type 2 diabetes.
|
| Company Name: |
Beijing Yisiyan Technology Research Center
|
| Tel: |
010-56645598 13366904824 |
| Email: |
bjkaida@163.com |
| Products Intro: |
Product Name:N-tert-butyl-6,7-dichloro-3-methylsulfonylquinoxalin-2-amine
CAS:281209-71-0
Purity:97% Package:25mg/;50mg/;100mg/;500mg/;1000mg/
|
| Company Name: |
Sigma-Aldrich
|
| Tel: |
021-61415566 800-8193336 |
| Email: |
orderCN@merckgroup.com |
| Products Intro: |
Product Name:GLP-1R agonist
CAS:281209-71-0
Purity:>=98% (HPLC) Package:5MG Remarks:G8048-5MG
|
|
| | Compound 2 Basic information |
| Product Name: | Compound 2 | | Synonyms: | Glucagon-Like Peptide 1 Receptor Agonist;2-Quinoxalinamine, 6,7-dichloro-N-(1,1-dimethylethyl)-3-(methylsulfonyl)-;6,7-dichloro-2-methylsulfonyl-3-N-tert-butylaminoquinoxaline (DMB);Compound 2;GLP-1R agonist;GLP-1R agonist DMB;N-(tert-butyl)-6,7-dichloro-3-(methylsulfonyl)quinoxalin-2-amine;Glucagon-Like Peptide 1 Receptor Agonist - CAS 281209-71-0 - Calbiochem | | CAS: | 281209-71-0 | | MF: | C13H15Cl2N3O2S | | MW: | 348.25 | | EINECS: | | | Product Categories: | | | Mol File: | 281209-71-0.mol |  |
| | Compound 2 Chemical Properties |
| Boiling point | 535.2±50.0 °C(Predicted) | | density | 1.423±0.06 g/cm3(Predicted) | | storage temp. | 2-8°C | | solubility | DMSO: ≥10mg/mL | | pka | -0.94±0.59(Predicted) | | form | Yellow solid | | color | light brown-yellow |
| Hazard Codes | Xn | | Risk Statements | 22 | | WGK Germany | 3 |
| | Compound 2 Usage And Synthesis |
| General Description | Glucagon-like peptide-1 receptor (GLP-1R) agonist is a potential oral drug for modulating glucagon-like peptide (GLP)-1 in diabetic patients. GLP-1R agonists play a key role in lowering glycated hemoglobin levels. It improves glycemic control and maintenance of body weight. | | Biochem/physiol Actions | GLP-1R is a small molecule GLP-1 receptor agonist. GLP-1 receptor signaling is a predominant mechanism for regulating glucose homeostasis. This compound represents a unique non-peptide tool for studying the role of GLP-1 in both in vivo and in vitro diabetes and obesity models. |
| | Compound 2 Preparation Products And Raw materials |
|